CN104587384A - Traditional Chinese medicine composition for treating depression - Google Patents

Traditional Chinese medicine composition for treating depression Download PDF

Info

Publication number
CN104587384A
CN104587384A CN201410856431.8A CN201410856431A CN104587384A CN 104587384 A CN104587384 A CN 104587384A CN 201410856431 A CN201410856431 A CN 201410856431A CN 104587384 A CN104587384 A CN 104587384A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
medicine composition
depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410856431.8A
Other languages
Chinese (zh)
Other versions
CN104587384B (en
Inventor
张桂铭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410856431.8A priority Critical patent/CN104587384B/en
Publication of CN104587384A publication Critical patent/CN104587384A/en
Application granted granted Critical
Publication of CN104587384B publication Critical patent/CN104587384B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating depression. The traditional Chinese medicine composition comprises 40 parts of ginseng, 25 parts of radix bupleuri, 30 parts of semen zizyphi spinosae;, 20 parts of radix astragali, 15 parts of radix salvia miltiorrhiza, 25 parts of concha ostreae, 10 parts of rhizoma acori graminei and 15 parts of radix curcumae. The clinic effective rate of the traditional Chinese medicine composition for treating depression disclosed by the invention reaches 95 percent.

Description

A kind of Chinese medicine composition of Cure of depression
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese medicine composition of Cure of depression.
Background technology
Depression is a kind of affective state of affective disorders, and affective disorders refers to the remarkable and lasting change (surging or low) of mental state for basic clinical, and with corresponding thinking and a dystropic class mental disorder.The main manifestations of depression is: depressed mood, pessimism, excitement are lost, energy goes down and is slow in action.Depressed mood is most crucial symptom.
Depression belongs to melancholia category in motherland's medical science, and the traditional Chinese medical science thinks that melancholia is because feelings will is not relaxed, the class disease caused by depression and stagnation of QI.Main manifestations is for feeling depressed, and irritable emotion, distending pain over the hypochondrium or irritability are apt to cry, and block if any foreign body in pharynx, the various complicated symptoms such as insomnia.Depressed is because feelings will hindered, depression of liver-QI, causes gradually caused by the five internal organs mechanism of qi discord.But mainly liver, spleen, the heart three are dirty gets involved and disorder of QI and blood forms.In a word, the traditional Chinese medical science thinks the generation of melancholia, because of disgruntled, ponder over, institute that is grieved, worried seven emotions hinders, cause the liver failing to maintain the normal flow of QI, spleen mistake transporting, the mind is not normal, and internal organs yin and yang qi and blood disorder forms.The first cause of disease stagnation of QI and hold damp-phlegm, food stagnation, heat stagnation person under the arm, then mostly empirical; Prolonged illness is by gas and blood, and Sthenia is transforming into asthenia, and overtax one's nerves as strongly fragrant for a long time, heart spleen all loses, and hyperactivity of fire caused by deficiency of YIN etc. all belong to deficiency syndrome.
Treatment at present for depression can adopt the medicines such as resist melancholy agent, tranquilizer, sleeping pill, psychosis, but toxic and side effects is large, has certain dependency and expensive.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, Chinese medicine composition to the Cure of depression of human non-toxic's side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilizes the property of medicine of Chinese medicine uniqueness, adopts Radix Ginseng, Radix Bupleuri, Semen Ziziphi Spinosae, the Radix Astragali, Radix Salviae Miltiorrhizae, Concha Ostreae, Rhizoma Acori Graminei, Radix Curcumae, according to certain compatibility requirement, through being processed into.
Chinese medicine composition of the present invention is made up of following raw material medicaments: Radix Ginseng 40 parts, Radix Bupleuri 25 parts, Semen Ziziphi Spinosae 30 parts, the Radix Astragali 20 parts, Radix Salviae Miltiorrhizae 15 parts, Concha Ostreae 25 parts, Rhizoma Acori Graminei 10 parts, Radix Curcumae 15 parts.
The pharmacological action of Chinese medicine of the present invention is as follows: Radix Ginseng: strongly invigorating primordial QI, invigorating the spleen to benefit the lung, promotes the production of body fluid, Fructus Alpiniae Oxyphyllae of calming the nerves; Radix Bupleuri: induce sweat bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy; Semen Ziziphi Spinosae: the liver benefiting that nourishes heart, calm the nerves, arresting sweating, to promote the production of body fluid; The Radix Astragali: air making-up and spleen enlivening, ascending up spleen-Qi and Yang, benefit defend consolidating superficial resistance, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening; Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, relieving restlessness are calmed the nerves; Concha Ostreae: tranquillization with heavy prescription, suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving, convergence are astringent or styptic treatment for spontaneous sweating; Rhizoma Acori Graminei: stomach, beneficial will of allaying excitement are closed in refreshment of having one's ideas straightened out, removing dampness; Radix Curcumae: promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.Full side, by invigorating vital QI, invigorate blood circulation tune blood, dispersing the stagnated live-QI to relieve the stagnation of QI and the mind calming and mentality promoting, reaches the object of Cure of depression.
Chinese medicine composition of the present invention was in 2011 to 2014 clinical observation depression in 60 cases patients, and clinical report is as follows:
1, physical data
In 60 routine patients, women 28 example, male 32 example, at minimum 16 years old of age, maximum 75 years old, the course of disease was many at 3 months to 5 years, 43.7 years old mean age.
2, diagnostic criteria
The diagnostic criteria of " Chinese Spirit Obstacles classification and diagnostic criteria the 3rd edition " (CCMD-3) depression, first 17 >=18 points of Hamilton depressive scale (HAMD), without other neuropsychiatric diseases, alcohol-free and drug dependence and similar medicine allergies, get rid of the diseases such as the heart, liver, kidney.
3, Therapeutic Method
3.1 prescriptions: Radix Ginseng 40 grams, Radix Bupleuri 25 grams, Semen Ziziphi Spinosae 30 grams, the Radix Astragali 20 grams, Radix Salviae Miltiorrhizae 15 grams, Concha Ostreae 25 grams, Rhizoma Acori Graminei 10 grams, Radix Curcumae 15 grams.
3.2 preparation methoies: said medicine routinely technique makes decoction.
3.3 instructions of taking: each 1 dose, every day 2 times 4 weeks was 1 course for the treatment of.
4, therapeutic outcome:
4.1 treatment evaluation criterias: adopt HAMD to evaluate clinical efficacy, with the evaluation of HAMD deduction rate, adopt recovery from illness, effective, invalid 3 grades of standards of grading, and deduction rate >=75% is recovery from illness, and 25 ~ 75% is that effectively < 25% is invalid.Total effective rate (%)=[(recovery from illness+effectively)/total number of cases] × 100%.
4.2 results: in 60 routine patients, 39 examples of fully recovering (65%), effective 18 examples (30%), invalid 3 examples (5%), total effective rate is 95%.
5, model case
5.1 men, 16 years old, Shandong people from county, because of learning pressure, normal insomnia, exchanging with people hypologia, less, was depression after diagnosing, medical history 1 year.The Chinese medicine composition taking Cure of depression of the present invention is treated, thorough rehabilitation after two courses for the treatment of.
5.2 male, 40 years old, Shandong people from county, suffered from depression, frequent heart occur gloomy, lonely, dreary, grieved, lose the interest exchanging dealing with kith and kin, the external world, frequently sigh, dejected, sobbing.Taken the Chinese medicine composition of Cure of depression of the present invention, after three courses for the treatment of, disease obtains recovery from illness.
5.3 female, 53 years old, cause work in 1 year was not smooth, and occur susceptible to lose temper due to restlessness, depressed, recent months exacerbation of symptoms, often flies into a rage, emotional, two side of body and distending pain of the breast, inappetence, insomnia and dreamful sleep, red tongue with yellow fur, stringy pulse.Taken the Chinese medicine composition of Cure of depression of the present invention, after two courses for the treatment of, disease obtains recovery from illness.
5.4 female, 30 years old, for many years, occurred depressed in recent years, insomnia increased the weight of, and sometimes lies awake all night, and often show effect stabbing hypochondrium pain, dysmenorrhea, dark tongue quality, stringy and hesitant pulse in insomnia.Taken the Chinese medicine composition of Cure of depression of the present invention, after three courses for the treatment of, disease obtains recovery from illness.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, and this embodiment following does not only limit the present invention for illustration of the present invention.
Embodiment 1, a kind of Chinese medicine composition of Cure of depression, it is made up of following raw material medicaments: Radix Ginseng 40 grams, Radix Bupleuri 25 grams, Semen Ziziphi Spinosae 30 grams, the Radix Astragali 20 grams, Radix Salviae Miltiorrhizae 15 grams, Concha Ostreae 25 grams, Rhizoma Acori Graminei 10 grams, Radix Curcumae 15 grams, above-mentioned raw materials medicine adds 8 times of weight ratio waters and decocts, filter, obtain decocting liquid, be pharmaceutical composition of the present invention.

Claims (2)

1. a Chinese medicine composition, is characterized in that being made up of following bulk drugs: Radix Ginseng 40 parts, Radix Bupleuri 25 parts, Semen Ziziphi Spinosae 30 parts, the Radix Astragali 20 parts, Radix Salviae Miltiorrhizae 15 parts, Concha Ostreae 25 parts, Rhizoma Acori Graminei 10 parts, Radix Curcumae 15 parts.
2. the purposes of Chinese medicine composition described in claim 1 in Cure of depression.
CN201410856431.8A 2014-12-17 2014-12-17 A kind of Chinese medicine composition for treating depression Expired - Fee Related CN104587384B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410856431.8A CN104587384B (en) 2014-12-17 2014-12-17 A kind of Chinese medicine composition for treating depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410856431.8A CN104587384B (en) 2014-12-17 2014-12-17 A kind of Chinese medicine composition for treating depression

Publications (2)

Publication Number Publication Date
CN104587384A true CN104587384A (en) 2015-05-06
CN104587384B CN104587384B (en) 2017-12-01

Family

ID=53113655

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410856431.8A Expired - Fee Related CN104587384B (en) 2014-12-17 2014-12-17 A kind of Chinese medicine composition for treating depression

Country Status (1)

Country Link
CN (1) CN104587384B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020130704A1 (en) * 2018-12-20 2020-06-25 대전대학교 산학협력단 Composition for preventing or treating depression or anxiety disorder, containing, as active ingredient, complex extract of astragali radix and salviae miltiorrhizae radix

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288761A (en) * 2008-06-06 2008-10-22 中国人民解放军第四军医大学 Chinese tmedicine preparation for treating depression and its preparation method
CN101850090A (en) * 2010-05-25 2010-10-06 刘宗英 Chinese medicinal preparation for treating insomnia depression
CN102416148A (en) * 2011-12-08 2012-04-18 南京海昌中药集团有限公司 Medicine for treating depression, and preparation method and application thereof
CN102861299A (en) * 2012-10-22 2013-01-09 成都中医药大学附属医院 Drug composition for treating depressive disorders, preparation method and application of drug composition
CN102861285A (en) * 2011-07-06 2013-01-09 天津太平洋制药有限公司 Anti-depression Chinese herbal medicine composition and preparation method for drop pills of anti-depression Chinese herbal medicine composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101288761A (en) * 2008-06-06 2008-10-22 中国人民解放军第四军医大学 Chinese tmedicine preparation for treating depression and its preparation method
CN101850090A (en) * 2010-05-25 2010-10-06 刘宗英 Chinese medicinal preparation for treating insomnia depression
CN102861285A (en) * 2011-07-06 2013-01-09 天津太平洋制药有限公司 Anti-depression Chinese herbal medicine composition and preparation method for drop pills of anti-depression Chinese herbal medicine composition
CN102416148A (en) * 2011-12-08 2012-04-18 南京海昌中药集团有限公司 Medicine for treating depression, and preparation method and application thereof
CN102861299A (en) * 2012-10-22 2013-01-09 成都中医药大学附属医院 Drug composition for treating depressive disorders, preparation method and application of drug composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
叶金竹等: "论抑郁症从心脾论治的理论基础", 《贵阳中医学院学报》 *
陈晓阳等: "忧虑康汤治疗抑郁症40例临床观察", 《中国中医药科技》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020130704A1 (en) * 2018-12-20 2020-06-25 대전대학교 산학협력단 Composition for preventing or treating depression or anxiety disorder, containing, as active ingredient, complex extract of astragali radix and salviae miltiorrhizae radix

Also Published As

Publication number Publication date
CN104587384B (en) 2017-12-01

Similar Documents

Publication Publication Date Title
CN103349756B (en) Traditional Chinese medicine composition for treating depression
CN103099944A (en) Drug for treating stubborn insomnia
CN100548352C (en) A kind of Chinese medicine composition of orally taken for curing depression
CN102406824A (en) Chinese medicine composition for treating insomnia
CN103550435B (en) Traditional Chinese medicine for treating tristimania
CN102178892B (en) Chinese medicinal composition for treating depression
CN103251888A (en) Chinese medicine composition for treating depression
CN102631450B (en) Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold
CN104587384A (en) Traditional Chinese medicine composition for treating depression
CN104784625A (en) Traditional Chinese medicine composition for treating insomnia
CN100364587C (en) Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method
CN103212019B (en) Chinese materia medica preparation for treating depression
CN102319406B (en) Medicament for treating tristimania
CN105381059A (en) Drug capable of relieving somnipathy
CN101129806A (en) Orally taken traditional Chinese medicine composition for treating melancholia
CN101721653A (en) Traditional Chinese medicine for treating hyperthyroidism
CN104225387A (en) Traditional Chinese medicine composition for treating damp-heat blocked type diabetes feet
CN104606650A (en) Traditional Chinese medicine composition treating insomnia
CN104162006A (en) Traditional Chinese medicine for treating sympathetic-type cervical spondylosis
CN103948777A (en) Traditional Chinese medicine for treating sinusitis
CN103446425A (en) Herbal bagged tea bag for treating chronic pharyngitis
CN102309732A (en) Traditional Chinese medicine pill for treating arrhythmia
Li et al. Whole medical systems in lung health and sleep: focus on traditional chinese medicine
CN105770759A (en) Traditional Chinese medicine for treating appendicitis
CN105148241A (en) Traditional Chinese medicine composition for treating depression

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171201

Termination date: 20181217